NASDAQ · STOCK
Clorox
$96.45
52W $84.70 – $132.03
52/100
$11.25B
14.9
0.55
Price History (6M)
Executive Summary
5 analysts weighed in with 40% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Growth Analyst: Growth rate is decelerating quarter over quarter -- the trend line matters more than the level. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
- Bullish candlestick pattern(s) detected: Morning Star.
- Bullish candlestick patterns signal potential reversal or continuation of upside.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- MACD histogram is negative (-0.109) — bearish momentum.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Risk/reward is unfavorable: 12.1% downside vs 4.4% upside.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
52/100
Agreement
43%
Analysts
7
Conviction
Contested
Growth Analyst
bearish
35
/ 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
53.9
Neutral
MACD Histogram
-0.110
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$84.76
Resistance
$100.70
Bollinger %B
0.59
Inside Bands
Price vs Moving Averages
EMA 9
$95.64
Above
EMA 21
$95.46
Above
EMA 50
$96.24
Above
EMA 200
$106.74
Below
Fundamental Analysis
Valuation
50
Growth
45
Profitability
79
Financial Health
2
Valuation
P/E Ratio
14.9×
P/B Ratio
46.10×
PEG Ratio
—
Dividend Yield
5.33%
52W High
$132.03
52W Low
$84.70
Quality & Growth
ROE
45368.0%
ROA
1307.0%
Gross Margin
4385.0%
Operating Margin
1462.0%
Revenue Growth YoY
-369.0%
Debt / Equity
7.86
AI Fundamental Assessment
P/E ratio of 14.9 (inexpensive relative to a 15-40x range); Price-to-book of 46.1x; Revenue growth (YoY) of -3.7%; EPS growth (YoY) of 10.6%; Return on equity of 453.7%; Return on assets of 13.1%; Net margin of 11.2%; Gross margin of 43.9%; Current ratio of 0.84 (tight short-term liquidity); Debt-to-equity of 7.86; Most recent quarter beat estimates by 4.7%; EPS growth decelerating (+63.5% -> +18.0% QoQ); Analyst estimates rising over recent quarters
Key Risks
- MACD histogram is negative (-0.109) — bearish momentum.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Risk/reward is unfavorable: 12.1% downside vs 4.4% upside.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full CLX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile